GET THE APP

Photophobia and Migraine Outcome during Treatment with Galca | 100768

న్యూరాలజీ & న్యూరోఫిజియాలజీ జర్నల్

ISSN - 2155-9562

నైరూప్య

Photophobia and Migraine Outcome during Treatment with Galcanezumab

Catherine Lapp

The Calcitonin Gene-Related Peptide (CGRP), which affects both migraine pain and accompanying symptoms including photophobia, is crucial to the physiology of migraines. The current study sought to determine if monoclonal antibodies that target CGRP are effective in lowering ictal photophobia as well as headache and migraine frequency and disability.

నిరాకరణ: ఈ సారాంశం కృత్రిమ మేధస్సు సాధనాలను ఉపయోగించి అనువదించబడింది మరియు ఇంకా సమీక్షించబడలేదు లేదా ధృవీకరించబడలేదు.